Role and mechanism of the alkylglycerone phosphate synthase in suppressing the invasion potential of human glioma and hepatic carcinoma cells in vitro

Oncology Reports

Volumn 32, Issue 1, 2014, Pages 431-436

  Zhu, Yu ^a   Zhu, Lielie ^b   Lu, Ling ^c   Zhang, Ling ^a   Zhang, Guodong ^a   Wang, Qin ^a   Yang, Ping ^a  

^a TIANJIN HUANHU HOSPITAL   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Alkylglycerone phosphate synthase; Glioma; Hepatic carcinoma; Invasion

Indexed keywords

ALKYLGLYCERONE PHOSPHATE SYNTHASE; GELATINASE A; GELATINASE B; HERMES ANTIGEN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID ETHER; PROSTAGLANDIN E2; SYNTHETASE; UNCLASSIFIED DRUG; UVOMORULIN; ALKYLGLYCERONE-PHOSPHATE SYNTHASE; LIPID; LYSOPHOSPHOLIPID; TRANSFERASE;

ARTICLE; CANCER INHIBITION; CD44 GENE; CONTROLLED STUDY; E CADHERIN GENE; ENZYME ACTIVITY; ENZYME ASSAY; GENE FUNCTION; GENE IDENTIFICATION; GLIOMA CELL LINE; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; MMP2 GENE; MMP9 GENE; MOLECULAR DYNAMICS; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR INVASION; CELL ADHESION; CELL CYCLE; ENZYMOLOGY; GENE SILENCING; GLIOMA; HEPG2 CELL LINE; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ALKYL AND ARYL TRANSFERASES; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL CYCLE; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HEP G2 CELLS; HUMANS; LIPIDS; LIVER NEOPLASMS; LYSOPHOSPHOLIPIDS; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS;

EID: 84903213693     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3189     Document Type: Article

References (16)

1. Zhang H, Nie W, Zhang X, Zhang G, Li Z, Wu H, Shi Q, Chen Y, Ding Z, Zhou X and Yu R: NEDD4-1 regulates migration and invasion of glioma cells through CNrasGEF ubiquitination in vitro. PLoS One 12: e82789, 2013.
2. Li Y, Shi X, Zhang J, Zhang X and Martin RC: Hepatic protection and anticancer activity of curcuma: A potential chemopreventive strategy against hepatocellular carcinoma. Int J Oncol 2: 505-513, 2014.
3. Kahlert UD, Nikkhah G and Maciaczyk J: Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Lett 2: 131-138, 2013.
4. Benjamin DI, Cozzo A, Ji X, Roberts LS, Louie SM, Mulvihill MM, Luo K and Nomura DK: Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity. Proc Natl Acad Sci USA 37: 14912-14917, 2013.
5. Liu Y, Zhao Y, Ju Q, Chen L, Li F, Zhou G, Xie P, Li G and Li Y: Molecular clone and functional study of a novel hepatoma associated gene. Int J Oncol 3: 1105-1112, 2013.
6. Zhu Y, Yang P, Wang Q, Hu J, Xue J, Li G, Zhang G, Li X, Li W, Zhou C, Zhao M and Wang D: The effect of CXCR4 silencing on epithelial-mesenchymal transition related genes in glioma U87 cells. Anat Rec (Hoboken) 12: 1850-1856, 2013.
7. Chen S, Wang J, Gou WF, Xiu YL, Zheng HC, Zong ZH, Takano Y and Zhao Y: The involvement of RhoA and Wnt-5a in the tumorigenesis and progression of ovarian epithelial carcinoma. Int J Mol Sci 12: 24187-24199, 2013.
8. Chen X, Xiao W, Chen W, Luo L, Ye S and Liu Y: The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells. Cell Death Dis 4: e884, 2013.
9. Koay MH, Crook M and Stewart CJ: Cyclin D1, E-cadherin and beta-catenin expression in FIGO Stage IA cervical squamous carcinoma: diagnostic value and evidence for epithelial-mesenchymal transition. Histopathology 6: 1125-1133, 2012.
10. La Monica S, Caffarra C, Saccani F, Galvani E, Galetti M, Fumarola C, Bonelli M, Cavazzoni A, Cretella D, Sirangelo R, Gatti R, Tiseo M, Ardizzoni A, Giovannetti E, Petronini PG and Alfieri RR: Gefitinib inhibits invasive phenotype and epithelialmesenchymal transition in drug-resistant NSCLC cells with MET amplification. PLoS One 10: e78656, 2013.
11. Ren D, Wang M, Guo W, Zhao X, Tu X, Huang S, Zou X and Peng X: Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR-145. Int J Oncol 4: 1473-1481, 2013.
12. Hsieh YS, Chu SC, Hsu LS, Chen KS, Lai MT, Yeh CH and Chen PN: Rubus idaeus L. reverses epithelial-to-mesenchymal transition and suppresses cell invasion and protease activities by targeting ERK1/2 and FAK pathways in human lung cancer cells. Food Chem Toxicol 62: 908-918, 2013.
13. Li NY, Weber CE, Wai PY, Cuevas BD, Zhang J, Kuo PC and Mi Z: An MAPK-dependent pathway induces epithelial-mesenchymal transition via Twist activation in human breast cancer cell lines. Surgery 2: 404-410, 2013.
14. Ferraro A, Mourtzoukou D, Kosmidou V, Avlonitis S, Kontogeorgos G, Zografos G and Pintzas A: EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control epithelialmesenchymal transition and anoikis in colon cancer cells. Int J Biochem Cell Biol 2: 243-254, 2013.
15. Pakala SB, Singh K, Reddy SD, Ohshiro K, Li DQ, Mishra L and Kumar R: TGF-β1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells. Oncogene 19: 2230-2241, 2011.
16. Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T and Nishida S: Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. J Exp Clin Cancer Res 1: 62, 2013.